Advertisement

Clinical Aspects of Growth Hormone Hypersecretory States

  • M. O. Thorner
  • M. L. Hartman
  • M. L. Vance
Conference paper

Abstract

Growth hormone (GH) is secreted by the anterior pituitary and the pattern of secretion in both human and animal species is pulsatile [6, 19]. Thus, there are episodes of enhanced growth hormone secretion which occur at varying intervals. At present it is not clear whether growth hormone is tonically secreted between secretory bursts or whether it is only secreted episodically. Episodic growth hormone secretion is thought to be mediated by dual stimulation by hypothalamic growth hormone releasing hormone (GHRH) associated with a reduction in the tonic secretion of somatostatin (growth hormone release inhibiting hormone: SS) [18, 22]. Evidence from animal studies indicates that pulses of growth hormone secretion require GHRH, since passive immunization with antibodies to GHRH abolishes these GH bursts [24]. In contrast, basal growth hormone secretion is apparently tonically inhibited by somatostatin since passive immunization with antibodies to somatostatin leads to an increase in basal GH secretion [25]. The exact nature of hypothalamic secretion of somatostatin and GHRH is speculated to be reciprocal (Fig. 1) [18, 22]. This hypothesis has been supported by direct sampling of hypophyseal-portal blood in rats [12].

Keywords

Growth Hormone Carpal Tunnel Syndrome Pituitary Tumor Growth Hormone Secretion Acromegalic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 12: 7–79CrossRefGoogle Scholar
  2. 2.
    Asa SL, Scheithauer BW, Bilbao JM, Horvath E, Ryan N, Kovacs K, Randall RV, Laws ER, Singer W, Linfoot JA, Thorner MO, Vale W (1984) A clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 58: 796–803CrossRefPubMedGoogle Scholar
  3. 3.
    Christy NP, Warren MP (1979) In: DeGroot LJ (ed) Disease syndromes of the hypothalamus and anterior pituitary. Endocrinology 1: 215–252Google Scholar
  4. 4.
    Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE (1979) Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 301: 1138–1142CrossRefPubMedGoogle Scholar
  5. 5.
    Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585–587CrossRefPubMedGoogle Scholar
  6. 6.
    Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987) Effects of sex and age on the 24 hour secretory profile of GH secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64: 51–58PubMedGoogle Scholar
  7. 7.
    Ituarte EA, Petrini J, Hershman JM (1984) Acromegaly and colon cancer. Ann Intern Med 101: 627–628CrossRefPubMedGoogle Scholar
  8. 8.
    Klein I, Parveen G, Gavaler JS, Van Thiel DH (1982) Colonic polyps in patients with acromegaly. Ann Intern Med 97: 27–30CrossRefPubMedGoogle Scholar
  9. 9.
    Kovacs K, Horvath E (1987) Pathology of pituitary adenomas. In: Molitch ME (ed) Endocrinology and Metabolism Clinics of North America 16: 529–551Google Scholar
  10. 10.
    McGuffin WL Jr, Sherman BM, Roth J, Gorden P, Kahn CR, Roberts WC, Frommer PL,(1974)Acromegaly and cardiovascular disorder. Ann Intern Med 81:11–18CrossRefPubMedGoogle Scholar
  11. 11.
    Pines A, Rozen P, Ron E, Gilat T (1985) Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 80: 266–269PubMedGoogle Scholar
  12. 12.
    Plotsky PM, Vale W (1985) Patterns of growth-hormone-releasing factor and somatostatin secretion into the hypophysealportal circulation of the rat. Science 230: 461–463CrossRefPubMedGoogle Scholar
  13. 13.
    Reichlin S (1974) Regulation of somatotrophic hormone secretion. In: Greep RO, Astwood EB, Knobil E, Sawyer WH, Geiger SR (eds) Endocrinology (Handbook of Physiology Sec 7 ), American Physiological Society, Washington, DC, pp 405–447Google Scholar
  14. 14.
    Reichlin S (1982) Acromegaly. Medical Grand Rounds 1: 9–24Google Scholar
  15. 15.
    Rivier J, Spiess J, Thorner M, Vale W (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300: 276–278CrossRefPubMedGoogle Scholar
  16. 16.
    Sassolas G, Chayvialle JA, Partensky C, Berger G, Trouillas J, Berger F, Claustrat B, Cohen R, Girod C, Guillemin R (1983) Acromegalie, expression clinique de la production de facteurs de liberation de l’hormone de croissance ( GRF) par une tumeur pancreatique. Ann Endocrinol (Paris) 44: 347–354Google Scholar
  17. 17.
    Soliman AT, Hassan AEHI, Aref MK, Hintz RC, Rosenfeld RG, Rogol AD (1986) Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20: 1122–1130CrossRefPubMedGoogle Scholar
  18. 18.
    Tannenbaum GS, Ling N (1984) The interrelationships of growth hormone ( GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115: 1952–1957Google Scholar
  19. 19.
    Tannenbaum GS, Martin JB (1976) Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98: 562–570CrossRefPubMedGoogle Scholar
  20. 20.
    Thorner MO, Frohman LA, Leong DA, Thominet J, Downs T, Hellmann P, Chitwood J,Vaughan JM,Vale W in collaboration with: Besser GM,Lytras N, Edwards CW,Schaaf M,Gelato M,Krieger DT,Marcovitz S,Ituarte E,Boyd AE,Malarkey WB,Blackard WG,Prioleau G,Melmed S,Charest NJ (1984) Extra-hypothalamic growth-hormone-releasing factor (GRF) secretion in a rare cause of acromehaly:Plasma GRF levels in 177 acromegalic patients.J Clin Endocrinol Metab 59:846–849Google Scholar
  21. 21.
    Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia: Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone releasing factor. J Clin Invest 70: 965–977Google Scholar
  22. 22.
    Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J, Thorner MO (1985) Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1–40). Evidence for intermittent somatostatin secretion. J Clin Invest 75: 1584–1590Google Scholar
  23. 23.
    Wass JAH (1987) Acromegaly. In: Besser GM, Dudworth AG (eds) Clinical Endocrinology, An Illustrated Text 3.1–3. 12. Gower Medical Publishing, LondonGoogle Scholar
  24. 24.
    Wehrenberg WB, Brazeau P, Luben R, Bohlen P, Guillemin R (1982) Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor ( GRF ). Endocrinology 111: 21–47Google Scholar
  25. 25.
    Wehrenberg WB, Ling N, Bohlen P, Esch F, Brazeau P, Guillemin R (1982) Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun 109: 562CrossRefPubMedGoogle Scholar
  26. 26.
    Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone releasing factor in obesity: A pituitary defect reversible with weight reduction. N Engl J Med 311: 1403–1407Google Scholar
  27. 27.
    Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in Acromegaly. Q J Med 39: 1–16PubMedGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1988

Authors and Affiliations

  • M. O. Thorner
    • 1
  • M. L. Hartman
    • 1
  • M. L. Vance
    • 1
  1. 1.Division of Endocrinology, Department of Internal MedicineUniversity of Virginia, School of MedicineCharlottesvilleUSA

Personalised recommendations